Perseus Proteomics Inc
TSE:4882
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
300
837
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Perseus Proteomics Inc
Perseus Proteomics Inc
Other Current Assets
Perseus Proteomics Inc
Other Current Assets Peer Comparison
2160
4587
4974
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Perseus Proteomics Inc
TSE:4882
|
Other Current Assets
¥21.3m
|
CAGR 3-Years
45%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
GNI Group Ltd
TSE:2160
|
Other Current Assets
¥1.4B
|
CAGR 3-Years
41%
|
CAGR 5-Years
42%
|
CAGR 10-Years
32%
|
|
|
PeptiDream Inc
TSE:4587
|
Other Current Assets
¥727.4m
|
CAGR 3-Years
54%
|
CAGR 5-Years
23%
|
CAGR 10-Years
30%
|
|
|
Takara Bio Inc
TSE:4974
|
Other Current Assets
¥2.7B
|
CAGR 3-Years
28%
|
CAGR 5-Years
27%
|
CAGR 10-Years
6%
|
|
S
|
StemRIM Inc
TSE:4599
|
Other Current Assets
¥214.1m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
C
|
Cuorips Inc
TSE:4894
|
Other Current Assets
¥28.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Perseus Proteomics Inc's Other Current Assets?
Other Current Assets
21.3m
JPY
Based on the financial report for Mar 31, 2024, Perseus Proteomics Inc's Other Current Assets amounts to 21.3m JPY.
What is Perseus Proteomics Inc's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
-16%
Over the last year, the Other Current Assets growth was 38%. The average annual Other Current Assets growth rates for Perseus Proteomics Inc have been 45% over the past three years , -16% over the past five years .
You don't have any saved screeners yet
